Year: 2004
Type: article
Abstract: everal clinical trials (1) have demonstrated that vitamin E does not reduce future major cardiovascular (CV) events.However, these trials could not rule out the potential benefit for highrisk subgroups.Diabetic individuals who are homozygous for the haptoglobin 2 allele (Hp 2-2) are at high risk for CV events (2-4); moreover, the Hp 2-2 protein product is an inferior antioxidant compared with the Hp 1 allele (5).We therefore hypothesized that vitamin E may reduce CV events in Hp 2-2 diabetic individuals.Hp type was measured in 3,167 participants (1,078 with diabetes) of the Heart Outcomes Prevention Evaluation (HOPE) trial, which evaluated the 4.5year effects of 400 IU vitamin E daily on the primary composite of CV death, myocardial infarction, and stroke (1).No significant benefit of vitamin E supplementation was detected in either the entire group or in the diabetic subset, consistent with what was previously reported for the entire HOPE cohort (1).In Hp 2-2 diabetic participants, there was a trend toward a reduced primary composite outcome (relative risk 0.70 [95% CI 0.45-1.10])and a statistically significant reduction in the risk of CV death (0.45 [0.23-0.90])and nonfatal myocardial infarction (0.57 [0.33-0.97]).However, this trend was not observed for strokes (1.15 [0.47-2.82]),and there was no statistical interaction between vitamin E use and haptoglobin type for either the composite outcome or any of its components.In conclusion, the absence of any statistical interaction indicates that these data do not support the hypothesis that the effects of vitamin E differed by Hp phenotype.Therefore, the results noted above in Hp 2-2 diabetic individuals demonstrating a significant reduction in CV death and myocardial infarction could be spurious and clearly require prospective testing in future trials.
Source: Diabetes Care
Institutions: Joslin Diabetes Center, Harvard University, University of Pecs
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2027465337